Immudex User Day - Philadelphia

"T-cells and Antigen-Specificity – Applications in Immuno-Oncology"

Join us this March in Philadelphia! This interactive event will bring together leading scientists to explore cutting-edge research on T-cell biology and antigen specificity, with a focus on its transformative applications in immuno-oncology.

Attendees will hear insightful presentations, engage in thought-provoking discussions, and connect with fellow users of Immudex’s products. Additionally, Immudex’s Chief Scientific Officer will provide an update on the newest technologies in our pipeline.

Whether you’re looking to share your research, spark new collaborations, or gain insights from expert presentations, this symposium promises a dynamic and inspiring environment for scientific exchange. Don’t miss this opportunity to be part of the conversation about deciphering adaptive immunity!

Lunch and drinks will be provided. Register now to secure your spot!

Date: 20 March 2025

Time: 09:00 – 15:00

Location: CIC Philadelphia

Registration Form

This event is free to attend but the number of places is limited so please register to secure your seat.

Program

9:00 - 9:15	Welcome and Announcements
9:15 - 9:45	Liselotte Brix, PhD - Co-founder and Chief Scientific Officer, Immudex Synthetic antigen presenting cell engagers – Simplify activation and expansion of specific T cells
9:50 - 10 :20	Muzamil Want, PhD - Scientist II, Department of Pediatrics, Division of Oncology, Children’s Hospital of Philadelphia Peptide-Centric CAR T-Cell Therapy for Solid tumors
10:20 - 10:50	Coffee Break
10:50 - 11:20	Deepali Krishan Bhat, PhD - Research Fellow, Surgery Branch, NCI, NIH Identifying Neo-antigen Specific TCRs for Enhanced Adoptive Cell Therapy in Advanced Cancers
11:25 - 11:55	Networking Event - Antigen Intelligence Bingo
12:00 - 1:00	LUNCH w/ optional round table discussions
1:00 - 1:30	Lauren Banks, MD, PhD - Medical Oncology Fellow, Klebanoff Lab, Memorial Sloan Kettering Cancer Center Discovering T cell receptors targeting fusion derived public neoantigens in desmoplastic small round cell tumor
1:35 - 2:05	Stephanie Glavaris, PhD Candidate - Vogelstein and Konig Lab, Johns Hopkins University TRBV9-Targeted Bispecific T Cell-Engaging Antibodies to Reset the Autoreactive T Cell Compartment in Spondyloarthritis and HLA-DQ8 Celiac Disease
2:10 - 3:00	Closing Remarks, Prizes & Networking

Meet the Team

Alessandra Audia, PhD

Head of Sales, North America

Chris Chuckran, PhD

Immune Monitoring Specialist

Liselotte Brix, PhD

Chief Scientific Officer